@article{TCR20961,
author = {Jan Norum},
title = {Pembrolizumab and other immunotherapies in patients with extensive-stage small-cell lung cancer—are we entering a new era?},
journal = {Translational Cancer Research},
volume = {7},
number = {Suppl 5},
year = {2018},
keywords = {},
abstract = {Small cell lung cancer (SCLC) is a very lethal and aggressive subtype of lung cancer, responsible for about 15% of all lung cancers (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/20961}
}